|
Novel use of Green Fluorescence Protein (GFP) and red fluorescence protein (RFP) and their derivatives to bind amyloid fibrils formed by enzymes, proteins, polypeptides, peptides, and hormones, both naturally occurring and lab-modified.
RPI ID: 2017-045-401Innovation Summary:Developed by RPI creators, this invention presents a novel system for detecting amyloid fibrils using engineered fluorescent proteins. The method enables sensitive and specific binding to amyloid aggregates, which are hallmarks of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. By leveraging the...
Published: 7/21/2025
|
Updated: 7/3/2025
|
Inventor(s): Changmingzi Xu-Fuery, Josephine LoRicco, Nathan James, Anthony Bishop, GEORGE MAKHATADZE
Keywords(s): Assay, biologic, biomarker, Biotechnology, Cellular Biology, Diagnostic system, Diagnostics, Drug Delivery, Drug Discovery, Human healthcare, Molecular Biology, pharmaceutical, protein/peptide, Proteins, research reagents/tools
Category(s): Biotechnology and the Life Sciences
|
